While Singapore has remained free of avian influenza, the risks persists. Read more at straitstimes.com. Read more at ...

Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger RNA—best ...

The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

A majority of Americans say childhood vaccines are effective at preventing illness, but slightly fewer are confident that the ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Pennsylvania’s short-term politics threaten its biotech future, driving innovation and opportunity to rival states.

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...